Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperacute rejection in heart allografts. Case studies.

J Kemnitz1, J Cremer, I Restrepo-Specht

  • 1Institute of Pathology, Hannover Medical School, FRG.

Pathology, Research and Practice
|January 1, 1991
PubMed
Summary

Hyperacute rejection, a rare heart transplant complication, presents with edema, hemorrhage, and myocyte necrosis. Prior cardiac surgeries and identical viral genomes in donor/recipient may increase risk.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes.

Leukemia·2007
Same author

Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies.

Histopathology·2006
Same author

Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia.

Leukemia·2004
Same author

Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2004
Same author

Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.

Annals of hematology·2003
Same author

Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial.

Leukemia·2003

Area of Science:

  • Cardiology
  • Transplantation Immunology
  • Pathology

Background:

  • Hyperacute rejection is a rare but severe complication following orthotopic heart transplantation.
  • Histopathological findings include edema, hemorrhages, and myocyte necrosis.